Mostrar el registro sencillo del ítem
Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death
dc.contributor.author | Martorell-Riera A. | |
dc.contributor.author | Segarra-Mondejar M. | |
dc.contributor.author | Muñoz J.P. | |
dc.contributor.author | Ginet V. | |
dc.contributor.author | Olloquequi J. | |
dc.contributor.author | Pérez-Clausell J. | |
dc.contributor.author | Palacín M. | |
dc.contributor.author | Reina M. | |
dc.contributor.author | Puyal J. | |
dc.contributor.author | Zorzano A. | |
dc.contributor.author | Soriano F.X. | |
dc.date.accessioned | 2020-09-02T22:22:23Z | |
dc.date.available | 2020-09-02T22:22:23Z | |
dc.date.issued | 2014 | |
dc.identifier | 10.15252/embj.201488327 | |
dc.identifier.citation | 33, 20, 2388-2407 | |
dc.identifier.issn | 02614189 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5218 | |
dc.description | Mitochondrial fusion and fission is a dynamic process critical for the maintenance of mitochondrial function and cell viability. During excitotoxicity neuronal mitochondria are fragmented, but the mechanism underlying this process is poorly understood. Here, we show that Mfn2 is the only member of the mitochondrial fusion/fission machinery whose expression is reduced in in vitro and in vivo models of excitotoxicity. Whereas in cortical primary cultures, Drp1 recruitment to mitochondria plays a primordial role in mitochondrial fragmentation in an early phase that can be reversed once the insult has ceased, Mfn2 downregulation intervenes in a delayed mitochondrial fragmentation phase that progresses even when the insult has ceased. Downregulation of Mfn2 causes mitochondrial dysfunction, altered calcium homeostasis, and enhanced Bax translocation to mitochondria, resulting in delayed neuronal death. We found that transcription factor MEF2 regulates basal Mfn2 expression in neurons and that excitotoxicity-dependent degradation of MEF2 causes Mfn2 downregulation. Thus, Mfn2 reduction is a late event in excitotoxicity and its targeting may help to reduce excitotoxic damage and increase the currently short therapeutic window in stroke. Synopsis Excitotoxicity leads to mitochondrial fragmentation, altered calcium homeostasis and neuronal death in two phases: a reversible Drp1-dependent one, followed by the irreversible degradation of MEF2, causing reduced Mfn2 transcription and Bax translocation to mitochondria. MEF2 regulates Mfn2 basal transcription in neurons. MEF2 degradation in excitotoxicity causes Mfn2 downregulation. Reduced Mfn2 expression causes mitochondrial dysfunction and altered calcium homeostasis. Mfn2 downregulation in excitotoxicity participates in delayed cell death by facilitating Bax recruitment to mitochondria. Excitotoxicity leads to mitochondrial fragmentation, altered calcium homeostasis and neuronal death in two phases: a reversible Drp1-dependent one, followed by the irreversible degradation of MEF2, causing reduced Mfn2 transcription and Bax translocation to mitochondria. © 2014 The Authors. | |
dc.language.iso | en | |
dc.publisher | Wiley-VCH Verlag | |
dc.subject | excitotoxicity | |
dc.subject | mitochondrial dynamics | |
dc.subject | neuron | |
dc.subject | transcriptional regulation | |
dc.subject | calcium ion | |
dc.subject | mitofusin 2 | |
dc.subject | myocyte enhancer factor 2 | |
dc.subject | protein Bax | |
dc.subject | Bax protein, rat | |
dc.subject | calcium | |
dc.subject | Drp1 protein, rat | |
dc.subject | dynamin | |
dc.subject | membrane protein | |
dc.subject | mitochondrial protein | |
dc.subject | mitofusin 2 protein, rat | |
dc.subject | myocyte enhancer factor 2 | |
dc.subject | protein Bax | |
dc.subject | animal cell | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | brain cell culture | |
dc.subject | brain ischemia | |
dc.subject | brain mitochondrion | |
dc.subject | brain nerve cell | |
dc.subject | calcium homeostasis | |
dc.subject | controlled study | |
dc.subject | disorders of mitochondrial functions | |
dc.subject | down regulation | |
dc.subject | excitotoxicity | |
dc.subject | female | |
dc.subject | gene expression regulation | |
dc.subject | gene translocation | |
dc.subject | in vitro study | |
dc.subject | in vivo study | |
dc.subject | male | |
dc.subject | mitochondrion | |
dc.subject | nerve cell necrosis | |
dc.subject | nonhuman | |
dc.subject | primary cell culture | |
dc.subject | protein degradation | |
dc.subject | protein expression | |
dc.subject | rat | |
dc.subject | transcription regulation | |
dc.subject | animal | |
dc.subject | cell culture | |
dc.subject | cell death | |
dc.subject | cell line | |
dc.subject | down regulation | |
dc.subject | gene expression regulation | |
dc.subject | genetics | |
dc.subject | homeostasis | |
dc.subject | human | |
dc.subject | metabolism | |
dc.subject | mitochondrial dynamics | |
dc.subject | mutation | |
dc.subject | nerve cell | |
dc.subject | physiology | |
dc.subject | Sprague Dawley rat | |
dc.subject | Animals | |
dc.subject | bcl-2-Associated X Protein | |
dc.subject | Calcium | |
dc.subject | Cell Death | |
dc.subject | Cell Line | |
dc.subject | Cells, Cultured | |
dc.subject | Down-Regulation | |
dc.subject | Dynamins | |
dc.subject | Gene Expression Regulation | |
dc.subject | Homeostasis | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | MEF2 Transcription Factors | |
dc.subject | Membrane Proteins | |
dc.subject | Mitochondria | |
dc.subject | Mitochondrial Dynamics | |
dc.subject | Mitochondrial Proteins | |
dc.subject | Models, Animal | |
dc.subject | Mutation | |
dc.subject | Neurons | |
dc.subject | Rats | |
dc.subject | Rats, Sprague-Dawley | |
dc.title | Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death | |
dc.type | Article |